Exploring the patient experience with Dr. D. Ross Camidge of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)
Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), discusses his diagnosis in 2022 of Stage IV EGFR-positive non-small cell lung cancer in an article published in ASTRO (American Society for Radiation Oncology) News.
Dr. Camidge also explores the cancer patient experience from his unique perspective as a treatment provider, researcher and patient in a Cracking Cancer podcast episode and a video interview with The Patient Story.
